Dr. Fang Liu is a senior scientist with the Brain Health Imaging Centre and the Tapscott Chair in Schizophrenia Studies at the Centre for Addiction and Mental Health (CAMH). She is also a professor and the director of the Division of Neuroscience and Clinical Translation in the Department of Psychiatry, University of Toronto.
Dr. Liu obtained her MD from Shanghai Medical University in China and practiced as a pediatrician before immigrating to Canada. She obtained her MSc and PhD from the Institute of Medical Sciences, University of Toronto. Dr. Liu joined the faculty of the Department of Psychiatry at the University of Toronto in 2001 and was promoted to full professor in 2011.
Areas of Research
Research in Dr. Liu's molecular neuroscience program at CAMH has focused on identification of novel biomarkers as well as novel targets for the development of protein peptide or small molecule therapeutics for the treatment of psychiatric diseases. Her research has led to a number of highly novel and internationally-recognized discoveries (e.g. Liu et al., Nature 2000; Lee et al., Cell 2002; Pei et al., Nature Medicine 2010; Su et al., Neuron 2014; Li et al.., Journal of Clinical Investigation 2020) that are being translated into potential novel therapeutics for treating neuropsychiatric disease such as depression, schizophrenia and PTSD.